Blood Pressure Medication: Prazosin is said to have cancer causing chemicals.
A major recall has been announced for more than 580,000 bottles of a commonly prescribed blood-pressure medication after tests found it may contain a potentially cancer-causing impurity.
The drug in question is Prazosin Hydrochloride also known under the brand name “Minipress” which is routinely used to lower high blood pressure by relaxing blood vessels.
What triggered the recall of the Blood Pressure Medication?
Earlier this month, Food and Drug Administration (FDA) testing found levels of a chemical impurity called N‑nitroso Prazosin impurity C in certain lots of the drug that exceeded the acceptable intake limits. These impurities belong to a class called nitrosamines, which are known to carry a risk of cancer when present in sufficient amounts.
The recall was issued on 7 October by Teva Pharmaceuticals USA and its distributor AmerisourceBergen among others, covering the 1 mg, 2 mg and 5 mg strengths of prazosin capsules.
How serious is it?
The FDA has classified this as a Class II recall, meaning the product “may cause temporary or medically reversible adverse health consequences,” and the probability of serious harm is considered remote.
Teva’s internal assessment judged the overall harm risk to patients as “medium”.
What should patients do?
If you are taking prazosin:
-
Check with your pharmacy or prescribing doctor whether your lot is among those recalled. It affects certain batches only (there were 55 lots listed).
-
Do not stop your medication suddenly without speaking to a healthcare professional treating your high blood pressure remains important.
-
Work with your doctor to arrange an appropriate alternative treatment if needed. Teva emphasised that “many alternative treatments are available”.
-
If you still have bottles from the affected lots, follow the return instructions from your pharmacy or the letter sent from Teva.
Why the recall of the Blood Pressure Medication matters?
Blood pressure remains one of the most common conditions managed by general practitioners, and drugs like prazosin play a vital role in everyday care. When a safety issue of this kind emerges it sends a ripple of concern through patients, doctors and pharmacies alike. The discovery of nitrosamine impurities echoes past recalls (such as those involving other drugs) and reminds us of the importance of rigorous quality controls in pharmaceutical manufacturing and storage.
The bigger picture
While this recall currently relates to specific batches of prazosin, it raises broader questions about how contaminants like nitrosamines can enter medications whether through manufacturing, degradation over time, or storage conditions. The FDA and drug makers are increasingly vigilant about nitrosamine contamination across many drug classes.
In short
If you are using prazosin, don’t panic but act promptly. Check that your supply is safe, consult your healthcare provider, and ensure you continue your treatment for hypertension in a safe way. And if you’re prescribed a new medication, this episode is a good reminder to ask: “Is this lot safe?”
